Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02711228

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:39.958103+00:00

Published At

2018-02-26T00:00:00+00:00

Record Updated At

2018-02-26

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Immune Deficiency", "Secondary Immune Deficiency"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-02-26"

protocolSection.identificationModule.nctId

"NCT02711228"

protocolSection.identificationModule.officialTitle

"Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra\u00ae) on Weekly and Biweekly Schedules"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Primary Immune Deficiency (protocolSection.conditionsModule.conditions)
• Secondary Immune Deficiency (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.